Douglas Carl Behenna

Person

  • San Juan Capistrano, CA, US

Patents Grantslast 30 patents

  • Information Patent Grant

    Imidazopyridazines as modulators of IL-17

    • Patent number 12,024,524
    • Issue date Jul 2, 2024
    • JANSSEN PHARMACEUTICA NV
    • Steven Goldberg
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CDK2 inhibitors

    • Patent number 11,773,082
    • Issue date Oct 3, 2023
    • Pfizer Inc.
    • Douglas Carl Behenna
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    CDK2 inhibitors

    • Patent number 11,718,603
    • Issue date Aug 8, 2023
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Imidazopyridazines as modulators of IL-17

    • Patent number 11,702,422
    • Issue date Jul 18, 2023
    • JANSSEN PHARMACEUTICA NV
    • Steven Goldberg
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Imidazopyridazines as modulators of IL-17

    • Patent number 11,691,979
    • Issue date Jul 4, 2023
    • JANSSEN PHARMACEUTICA NV
    • Steven Goldberg
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CDK2/4/6 inhibitors

    • Patent number 11,396,512
    • Issue date Jul 26, 2022
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Anti-proliferative agents for treating PAH

    • Patent number 11,203,594
    • Issue date Dec 21, 2021
    • Pfizer Inc.
    • Samit Kumar Bhattacharya
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    CDK2 inhibitors

    • Patent number 11,014,911
    • Issue date May 25, 2021
    • Pfizer Inc.
    • Douglas Carl Behenna
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    CDK2/4/6 inhibitors

    • Patent number 10,800,783
    • Issue date Oct 13, 2020
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Purine derivatives

    • Patent number 9,290,496
    • Issue date Mar 22, 2016
    • Pfizer Inc.
    • Douglas Carl Behenna
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    CDK2 INHIBITORS

    • Publication number 20240294506
    • Publication date Sep 5, 2024
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17

    • Publication number 20230357254
    • Publication date Nov 9, 2023
    • Janssen Pharmaceutica N.V.
    • Steven GOLDBERG
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS

    • Publication number 20230147458
    • Publication date May 11, 2023
    • Janssen Pharmaceutica N.V.
    • Steven D. Goldberg
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17

    • Publication number 20230081548
    • Publication date Mar 16, 2023
    • Janssen Pharmaceutica N.V.
    • Steven GOLDBERG
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17

    • Publication number 20220402922
    • Publication date Dec 22, 2022
    • JANSSEN BIOTECH, INC.
    • Steven GOLDBERG
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CDK2/4/6 Inhibitors

    • Publication number 20220324872
    • Publication date Oct 13, 2022
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CRYSTALLINE FORM OF A CDK INHIBITOR

    • Publication number 20220127262
    • Publication date Apr 28, 2022
    • Pfizer Inc.
    • Douglas Carl Behenna
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CDK2 INHIBITORS

    • Publication number 20210269425
    • Publication date Sep 2, 2021
    • Pfizer Inc.
    • Douglas Carl Behenna
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CDK2 INHIBITORS

    • Publication number 20210261530
    • Publication date Aug 26, 2021
    • Pfizer Inc.
    • Douglas Carl Behenna
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CDK2/4/6 Inhibitors

    • Publication number 20200392142
    • Publication date Dec 17, 2020
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH

    • Publication number 20200331909
    • Publication date Oct 22, 2020
    • Pfizer Inc.
    • Samit Kumar Bhattacharya
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CDK2 INHIBITORS

    • Publication number 20200247784
    • Publication date Aug 6, 2020
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CDK2/4/6 Inhibitors

    • Publication number 20190135817
    • Publication date May 9, 2019
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CDK2/4/6 Inhibitors

    • Publication number 20180044344
    • Publication date Feb 15, 2018
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PURINE DERIVATIVES

    • Publication number 20150141402
    • Publication date May 21, 2015
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY